BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.80
+0.01 (0.11%)
Apr 28, 2026, 4:00 PM EDT - Market closed
BBOT Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Market Capitalization | 704 | 1,001 | 247 | - |
| Market Cap Growth | 178.68% | 305.70% | - | - |
| Enterprise Value | 282 | 536 | - | - |
| Last Close Price | 8.80 | 12.52 | 10.50 | - |
| PB Ratio | 1.71 | 2.44 | 1.71 | - |
| P/TBV Ratio | 1.71 | 2.44 | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | - | - |
| Net Debt / Equity Ratio | -1.03 | -1.03 | -1.07 | 0.02 |
| Net Debt / EBITDA Ratio | 2.90 | 2.90 | 1.93 | 0.00 |
| Net Debt / FCF Ratio | 3.69 | 3.69 | 2.83 | 0.01 |
| Quick Ratio | 12.15 | 12.15 | 7.95 | 0.12 |
| Current Ratio | 12.34 | 12.34 | 8.11 | 0.24 |
| Return on Equity (ROE) | -48.23% | -48.23% | -110.95% | - |
| Return on Assets (ROA) | -29.75% | -29.75% | -59.37% | - |
| Return on Capital Employed (ROCE) | -35.30% | -35.30% | -55.90% | 597.90% |
| Earnings Yield | -19.03% | -13.38% | -30.09% | - |
| FCF Yield | -16.26% | -11.43% | -22.31% | - |
| Buyback Yield / Dilution | -241276.23% | -241276.23% | 89.66% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.